Hôpital Intercommunal de Créteil

Futó vizsgálatok

• Még nem toboroz

  Evaluation of the Effect of Time of Administration on the Activity on First Line of Pembrolizumab in Association With Carboplatin-pemetrexed in Metastatic Non-squamous Lung Cancer. A Randomised Multicenter Phase III Trial

  NCT07915037· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Még nem toboroz

  FirST Lines of Biologics in pAtients With ulceRaTivE Colitis: a Randomised Controlled Trial

  NCT07576452· 4. fázis· University Hospital, Clermont-Ferrand· Forrás

• Még nem toboroz

  A Study of Ivonescimab Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants with Unresectable Stage III NSCLC

  2026-526300-67-00· 3. fázis· Summit Therapeutics Inc.· Forrás

• Még nem toboroz

  Office Hysteroscopy Versus Operating-room Hysteroscopy for Uterine Lesions

  NCT07908615· Nantes University Hospital· Forrás

• Még nem toboroz

  Comparative Study of Two Vaccination Schedules for the Subunit Herpes Zoster Vaccine in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disease Patients Treated With Anti-CD20 Therapy: an Open-label Randomised Controlled Trial

  NCT07818356· 4. fázis· University Hospital, Toulouse· Forrás

• Toboroz

  Evaluating Aganirsen Eye Drops to Reduce the Number of Aflibercept Injections in Wet Age-Related Macular Degeneration Patients.

  2026-526775-27-00· 2. fázis· Laboratoires Kol· Forrás

• Még nem toboroz

  Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

  NCT07420439· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Még nem toboroz

  Impact of discontinuation of long-term macrolides in stable Non Cystic Fibrosis Bronchiectasis : a multicenter randomized controlled trial

  2025-521493-33-00· 3. fázis· Centre Hospitalier Intercommunal Creteil· Forrás

• Toboroz

  Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

  NCT07360743· 2. fázis· UNICANCER· Forrás

• Toboroz

  A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D Mutation

  NCT07566052· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Toboroz

  Personalizing chemotherapy selection after surgery for patients with stage III colorectal cancer using a blood test

  2025-521045-24-00· 3. fázis· Unicancer· Forrás

• Toboroz

  A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis

  NCT07516951· 2. fázis· Chiesi Farmaceutici S.p.A.· Forrás

• Toboroz

  Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma who progressed within 6 months of multimodality therapy for locally advanced disease.

  2025-521437-88-00· 2. fázis· Groupe Oncologie Radiotherapie Tete Cou· Forrás

• Toboroz

  A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

  NCT07365241· 3. fázis· AbbVie· Forrás

• Toboroz

  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  2025-522818-23-00· 3. fázis· Zai Lab (US) LLC· Forrás

• Toboroz

  A clinical trial of EYE201/MK-8748 in people with macular degeneration (MK-8748-003)

  2025-524894-17-00· 2/3. fázis· Eyebiotech Limited· Forrás

• Toboroz

  Optimal Care With Guselkumab in Crohn's Disease / OPTIM Study A Prospective Open Label Interventional, Multicenter Study

  NCT07616687· 4. fázis· Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives· Forrás

• Toboroz

  A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)

  NCT07554339· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  Study Comparing Ivonescimab Alone or Ivonescimab in Combination With Ligufalimab Versus Pembrolizumab for the Treatment of SCCHN

  NCT07264075· 3. fázis· Groupe Oncologie Radiotherapie Tete et Cou· Forrás

• Toboroz

  A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

  NCT07496567· 2/3. fázis· EyeBiotech Ltd.· Forrás

• Toboroz

  Trial assessing fianlimab plus cemiplimab plus chemotherapy or cemiplimab plus chemotherapy in patients with pleural mesothelioma

  2024-519208-29-00· 2. fázis· Intergroupe Francophone De Cancerologie Thoracique· Forrás

• Toboroz

  A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

  NCT07556159· 4. fázis· Sanofi· Forrás

• Toboroz

  Pharmacokinetics, Efficacy and Safety of Twice Daily Dosing Regimen of Hydroxycarbamide Dispersible Tablets in Children with Sickle Cell Disease: a single-group, non-randomised, open-label study (KID-BID)

  2024-513750-30-00· 2. fázis· Theravia· Forrás

• Toboroz

  MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013)

  NCT07431827· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Toboroz

  A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

  NCT07441642· 2. fázis· Novartis Pharmaceuticals· Forrás

• Toboroz

  A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

  NCT07063745· 2/3. fázis· Bristol-Myers Squibb· Forrás

• Toboroz

  A trial to learn how well AZD0292 works, how safe it is, and how it moves throughout the body over time in people with bronchiectasis and chronic PsA colonization

  2025-523009-14-00· 2. fázis· AstraZeneca AB· Forrás

• Toboroz

  Withdrawal of Dupilumab in Severe Asthma

  NCT06818019· 4. fázis· University Hospital, Toulouse· Forrás

• Toboroz

  Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

  NCT06908993· 3. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Toboroz

  A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)

  NCT07218146· 3. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás

• Toboroz

  A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

  NCT06804811· 3. fázis· Incyte Corporation· Forrás

• Toboroz

  Adjuvant Chemotherapy +/- Cemiplimab and Sequential Hypofractionated Radiotherapy in Unfit or Elderly Patients With Stage III Lung Cancer

  NCT06656598· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Toboroz

  Study to Assess the Injection Burden, Adverse Events, Change in Disease Activity, and Long-Term Preservation of Visual Acuity of Surabgene Lomparvovec in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD)

  NCT07007065· 3. fázis· AbbVie· Forrás

• Toboroz

  Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer

  NCT06899126· 3. fázis· Daiichi Sankyo· Forrás

• Toboroz

  Clinical Trial Comparing Induction Treatment With EGFR-ADC MRG003 Alone or in Combination With the Anti PD1 Pucotenlimab, Followed by Radiochemotherapy in Locally Advanced Squamous Cell Cancers of the Head and Neck

  NCT06959108· 2. fázis· Groupe Oncologie Radiotherapie Tete et Cou· Forrás

• Toboroz

  Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide versus Durvalumab, Carboplatin, and Etoposide in First-Line ES-SCLC (DeLLphi-312)

  2024-520050-38-00· 3. fázis· Amgen Inc.· Forrás

• Toboroz

  Efficacy and Safety of Tocilizumab for Acute Chest Syndrome Treatment in Patients With Sickle Cell Disease

  NCT06818266· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Fut, nem toboroz

  A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)

  NCT07005128· 3. fázis· Amgen· Forrás

• Toboroz

  Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  NCT07044336· 3. fázis· AstraZeneca· Forrás

• Még nem toboroz

  Comparison of the Sensibility of Swept Source Optical Coherence Tomography Devices in the Detection of Neovascularisation in Large Pigment Epithelium Detachments

  NCT07143526· University of Trieste· Forrás

• Toboroz

  This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  NCT06758401· 3. fázis· Pfizer· Forrás

• Toboroz

  Intranasal Sufentanil for Analgesia of Severe Sickle Cell Vaso-occlusive Pain Crisis in the Pediatric Emergency Department

  2023-504847-15-00· 3. fázis· Assistance Publique Hopitaux De Paris· Forrás

• Toboroz

  Study of Sacituzumab Govitecan Versus Standard of Care in Participants with Previously Treated Extensive Stage Small Cell Lung Cancer

  2024-515884-69-00· 3. fázis· Gilead Sciences Inc.· Forrás

• Toboroz

  Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy

  NCT06840834· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Még nem toboroz

  Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial

  NCT06263816· 3. fázis· University Hospital, Tours· Forrás

• Toboroz

  Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 antiviral treatment relief strategies, in patients co-infected with the HIV-1 and HBV viruses

  2023-508634-34-00· 2. fázis· Inserm· Forrás

• Toboroz

  Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

  NCT06881784· 3. fázis· Revolution Medicines, Inc.· Forrás

• Toboroz

  A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

  NCT06892548· 1/2. fázis· BioNTech SE· Forrás

• Toboroz

  Corticodependent or Corticoresistant Brain Radionecrosis After Radiotherapy for Brain Metastases

  NCT06471465· 3. fázis· Institut Cancerologie de l'Ouest· Forrás

• Fut, nem toboroz

  A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME

  NCT06957080· 2/3. fázis· EyeBiotech Ltd.· Forrás

Showing 50 of 143.

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Tüdőrák37 toboroz
• Időskori makuladegeneráció9 toboroz
• Sarlósejtes vérszegénység5 toboroz
• Asztma4 toboroz
• Bronchiectasis3 toboroz
• Fej-nyaki daganatok3 toboroz
• Cisztás fibrózis2 toboroz
• Crohn-betegség2 toboroz
• Idiopátiás tüdőfibrózis2 toboroz
• Liver cirrhosis2 toboroz
• Magas vérnyomás2 toboroz
• Neuroendokrin daganatok2 toboroz
• Brain metastases1 toboroz
• Colitis ulcerosa1 toboroz
• Diabéteszes retinopátia1 toboroz
• Elhízás1 toboroz
• HIV-fertőzés1 toboroz
• Krónikus obstruktív tüdőbetegség (COPD)1 toboroz
• Méhnyakrák1 toboroz
• Méhtestrák1 toboroz
• Mezotelióma1 toboroz
• Migrén1 toboroz
• Neuromyelitis optica (NMOSD)1 toboroz
• Petefészekrák1 toboroz
• Sarcoidosis1 toboroz
• Sclerosis multiplex (SM)1 toboroz
• Uterine fibroids1 toboroz
• Vastagbélrák1 toboroz

Lezárt vizsgálatok

• Lezárult

  A Phase 2 Study of Petosemtamab in Combination with Pembrolizumab in Adults with NSCLC

  2025-522867-13-00· 2. fázis· Merus B.V.· Forrás

• Visszavonták

  Study to Investigate Petosemtamab in Adults With Metastatic Non-Small Cell Lung Cancer

  NCT07353957· 2. fázis· Genmab· Forrás

• Fut, nem toboroz

  Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

  2025-521115-40-00· 2. fázis· Bicycletx Limited· Forrás

• Lezárult

  A trial to learn how well benralizumab works and how safe it is when given in addition to standard asthma treatments in people with eosinophilic asthma

  2024-515162-13-00· 3. fázis· AstraZeneca AB· Forrás

• Toboroz

  A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy

  2023-507097-41-01· 3. fázis· Shanghai Junshi Biosciences Co. Ltd.· Forrás

• Lezárult

  Evaluation of Grass Pollen Sensitization Among Professionals Exposed or Not Exposed to Flour

  NCT06727825· Centre Hospitalier Intercommunal Creteil· Forrás

• Leállították

  LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)

  NCT06558799· 2. fázis· NovoCure GmbH· Forrás

• Lezárult

  A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

  NCT06261957· 3. fázis· GlaxoSmithKline· Forrás

• Lezárult

  A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS-01 Eye Drops in Subjects With Diabetic Macular Edema

  2023-507207-66-00· 3. fázis· Oculis Operations S.a.r.l.· Forrás

• Lezárult

  A 52-week Clinical Trial to Study the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)

  NCT05813288· 3. fázis· Areteia Therapeutics Inc.· Forrás

• Lezárult

  Study comparing radiotherapy combined with cetuximab + Xevinapant (study drug) with radiotherapy combined with cetuximab + placebo in patients with head and neck cancer.

  2022-502584-38-00· 3. fázis· Groupe Oncologie Radiotherapie Tete Cou· Forrás

• Toboroz

  DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

  NCT05882058· 2. fázis· Boehringer Ingelheim· Forrás

• Lezárult

  Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

  NCT05882734· 1/2. fázis· EMD Serono Research & Development Institute, Inc.· Forrás

• Meghívásos bevonás

  Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With Migraine

  NCT05707949· 3. fázis· AbbVie· Forrás

• Lezárult

  A study to assess efficacy and safety of benralizumab in paediatric patients with severe eosinophilic asthma (severe asthma marked by high level of a type of white blood cells - eosinophils)

  2022-501344-14-00· 3. fázis· Astrazeneca AB· Forrás

• Toboroz

  A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

  NCT05711394· 3. fázis· AbbVie· Forrás

• Lezárult

  Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)

  NCT05630820· 3. fázis· GlaxoSmithKline· Forrás

• Fut, nem toboroz

  Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del

  NCT05331183· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Fut, nem toboroz

  Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation

  NCT05609578· 2. fázis· Mirati Therapeutics Inc.· Forrás

• Lezárult

  Long-term Comparative Cerebrovascular Outcome After Transplantation vs Standard Care in Sickle Cell Anemia

  NCT05053932· Centre Hospitalier Intercommunal Creteil· Forrás

• Lezárult

  Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy

  NCT05536297· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás

• Fut, nem toboroz

  A Phase III Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Non Small Cell Lung Cancer (NSCLC) Whose Disease Progressed On or After Prior Anti PD (L)1 Therapy And Platinum Based Chemotherapy

  NCT05450692· 3. fázis· AstraZeneca· Forrás

• Fut, nem toboroz

  Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

  NCT05403385· 2. fázis· iTeos Therapeutics· Forrás

• Lezárult

  Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)

  NCT05153239· 3. fázis· PharmaMar· Forrás

• Lezárult

  A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)

  NCT05546905· Pierre Fabre Medicament· Forrás

• Felfüggesztve

  Anakinra vs Prednisone to Treat Gout Flare in Patients With Chronic Kidney Disease Stage 4/5 or Renal Transplantation

  NCT04844814· 2. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

  NCT05030155· 3. fázis· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  A Study of Danicopan in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

  NCT05019521· 2. fázis· Alexion Pharmaceuticals Inc.· Forrás

• Lezárult

  Development of a Severity Assessment Score for Nasosinus Polyposis (PSI Score)

  NCT05056714· Centre Hospitalier Intercommunal Creteil· Forrás

• Lezárult

  A Study of VX-121 Combination Therapy in Participants With Cystic Fibrosis (CF) Who Are Homozygous for F508del, Heterozygous for F508del and a Gating (F/G) or Residual Function (F/RF) Mutation, or Have At Least 1 Other Triple Combination Responsive (TCR) CFTR Mutation and No F508del Mutation

  NCT05076149· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás

• Lezárult

  Comparison of Corticosteroids vs Placebo on Duration of Ventilatory Support During Severe Acute Exacerbations of COPD Patients in the ICU

  NCT04163536· 3. fázis· Versailles Hospital· Forrás

• Lezárult

  A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA

  NCT04822350· Pfizer· Forrás

• Lezárult

  A Phase 3, Randomized, Double-Blind Study of Ociperlimab, an Anti-TIGIT Antibody, in Combination With Tislelizumab Compared to Pembrolizumab in Patients With Previously Untreated, PD-L1-Selected, and Locally Advanced, Unresectable, or Metastatic Non-Small Cell Lung Cancer

  NCT04746924· 3. fázis· Beigene Ltd.· Forrás

• Leállították

  Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

  NCT04868877· 1/2. fázis· Merus B.V.· Forrás

• Lezárult

  An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

  NCT04770545· 3. fázis· Apellis Pharmaceuticals, Inc.· Forrás

• Fut, nem toboroz

  Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation

  NCT04685135· 3. fázis· Mirati Therapeutics Inc.· Forrás

• Lezárult

  Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer

  NCT04736173· 2. fázis· Arcus Biosciences, Inc.· Forrás

• Fut, nem toboroz

  PEmbRolizumab verSus chEmotherapy and pEmbrolizumab in Non-small-cell Lung Cancers (NSCLC) With PDL1 ≥ 50 %

  NCT04547504· 3. fázis· University Hospital, Brest· Forrás

• Lezárult

  Pilot and Phase 2 Study of the Efficacy of a Treatment Protocol With Dexamethasone Implant Loading Dose in Patients With Diabetic Macular Edema (LOADEX)

  NCT04116398· 2. fázis· Hospices Civils de Lyon· Forrás

• Lezárult

  A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS2)

  NCT04396574· 3. fázis· Eli Lilly & Co.· Forrás

• Lezárult

  A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine (PIONEER-PEDS1)

  NCT04396236· 3. fázis· Eli Lilly & Co.· Forrás

• Lezárult

  Placebo-controlled Study Comparing Niraparib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab as Maintenance Therapy in Participants With Advanced/Metastatic Non-Small Cell Lung Cancer

  NCT04475939· 3. fázis· GlaxoSmithKline· Forrás

• Toboroz

  Bougie Sleeve Trial

  NCT02937649· Assistance Publique - Hôpitaux de Paris· Forrás

• Lezárult

  Phase 3 Study of Pyrotinib Versus Docetaxel in Patients With Advanced Non-squamous NSCLC Harboring a HER2 Exon 20 Mutation Who Failed Platinum Based Chemotherapy

  NCT04447118· 3. fázis· Jiangsu HengRui Medicine Co., Ltd.· Forrás

• Lezárult

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· 2. fázis· Oxurion· Forrás

• Lezárult

  Study of Osimertinib in Patients with a Lung Cancer with Brain or Leptomeningeal Metastases with EGFR Mutation

  NCT04233021· 2. fázis· Intergroupe Francophone de Cancerologie Thoracique· Forrás

• Lezárult

  A Study Evaluating Platinum-Pemetrexed-Atezolizumab (+/-Bevacizumab) for Patients With Stage IIIB/IV Non-squamous Non-small Cell Lung Cancer With EGFR Mutations, ALK Rearrangement or ROS1 Fusion Progressing After Targeted Therapies

  NCT04042558· 2. fázis· Centre Francois Baclesse· Forrás

• Lezárult

  A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer

  NCT03596866· 3. fázis· Takeda· Forrás

• Lezárult

  UTOLA: UTerin OLAparib

  NCT03745950· 2. fázis· ARCAGY/ GINECO GROUP· Forrás

• Lezárult

  A Study of Brigatinib in Participants With Anaplastic Lymphoma Kinase-Positive (ALK+), Advanced Non-Small-Cell Lung Cancer (NSCLC) Progressed on Alectinib or Ceritinib

  NCT03535740· 2. fázis· Ariad Pharmaceuticals· Forrás

Showing 50 of 63.

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Időskori makuladegeneráció19 munka · 18 vizsgálat